HPS Pharmacies wish to advise that Sandoz Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA) have given notice of a drug recall of:
Curam® Duo Forte 875mg/125mg Tablets 10 strip
amoxycillin trihydrate 875mg + potassium clavulanate 125mg
Batches: CL9715, CN9455
Aust R: 82829
This recall has been issued due to a routine stability study leading to the identification of clavulanic acid degradation
Investigation revealed that damage to the foil seals allowed moisture to enter the packaging, causing degradation of potassium clavulanateic acid over time. This presents no direct risk to patients, however the product has suffered a loss of potency.
Please inspect your stocks and quarantine all products from the batches listed above for return to your supplier for a refund. Any items supplied by HPS Pharmacies may be returned to the pharmacy for processing.
Retain this notice in a prominent position, including in other related business units for one month, or until normal supply resumes.
Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or Sandoz Medical Information on 1800 726 369.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.